<p>Researchers are always looking for new treatments for advanced-stage breast cancer. Dr. Nicholas Turner explains the results of the CAPitello-291 trial, looking capivasertib, an experimental targeted therapy medicine, in combination with Faslodex (chemical name: fulvestrant) as a treatment for advanced-stage, hormone receptor-positive, HER2-negative breast cancer that has become resistant to the aromatase inhibitors.</p><p>Listen to the episode to hear Dr. Turner explain:</p><ul>
<li>how capivasertib works</li>
<li>the results of the CAPitello-291 trial</li>
<li>how capivasertib worked on cancers previously treated with a CDK4/6 inhibitor</li>
</ul>

Researchers are always looking for new treatments for advanced-stage breast cancer. Dr. Nicholas Turner explains the results of the CAPitello-291 trial, looking capivasertib, an experimental targeted therapy medicine, in combination with Faslodex (chemical name: fulvestrant) as a treatment for advanced-stage, hormone receptor-positive, HER2-negative breast cancer that has become resistant to the aromatase inhibitors. Listen to the episode to hear Dr. Turner explain: how capivasertib works the results of the CAPitello-291 trial how capivasertib worked on cancers previously treated with a CDK4/6 inhibitor

Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

New episodes publish every Tuesday at 5 a.m. ET.

Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.

Medicine

Health & Fitness

Education

New episodes publish every Tuesday at 5 a.m. ET. Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.

Share Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

Sign up to save your podcasts

Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

Experimental Capivasertib Seems Promising for Advanced-Stage, Hormone Receptor-Positive, HER2-Negative Breast Cancer

More shows like Breastcancer.org Podcast

TED Radio Hour

Well Beyond 40

The mindbodygreen Podcast

Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast

The Proof with Simon Hill

Dhru Purohit Show

The Dr. Hyman Show

Breast Cancer Conversations

Life Kit

This Is So Awkward

Dr. Streicher’s Inside Information: Menopause, Midlife, and More

The Mel Robbins Podcast

The Dr. Gabrielle Lyon Show

Keeping Abreast with Dr. Jenn

The Menopause and Cancer Podcast